Login

Interpump Unveils Innovative Solutions at IAA | Fabio Marasi - CEO of Interpump Group S.p.A. 00:10:00

Share On Facebook Share On Twitter

Fabio Marasi is the CEO of Interpump Group.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Precision in Small-Cap Investing: Magnus Larsson on TimesSquare’s Approach | Magnus Larsson – Portfolio Manager, TimesSquare Capital Management
00:10:00
Edward Jones 2024 Purpose, Inclusion, and Citizenship Report: Partnering for Positive Impact | Penny Pennington, Managing Partner , Edward Jones Investments.
00:10:00
Resuming Mining at Gaspé Copper Site in Quebec: Key Points and Future Prospects
00:10:00
PCI Pal has achieved significant revenue growth and margin improvement|CEO ,Cbo Territoria SA
00:10:00
Spire Mining: Pioneering Mongolia's Coking Coal Industry with Strategic Investments
00:10:00
"Demystifying Asset Classes | Part 1: Bonds, Equities, and Cash | Insights from BlackRock UK"
00:10:00
The Age of Equities May Be Over: Insights from Jonathan Ruffer
00:10:00
CEO Ben Lightburn Discusses Advancing Psychedelic Medicine through Natural Extraction | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Black and Chinese influence his relationship with mone|Ryan Alexander Holmes,Actor & Content Creator
00:10:00
Interface of technology and life sciences to transform the trajectory of life on earth|Zavain Dar,Partner,Dimension
00:10:00
ERD Resources Set to Ramp Up Gold Production in 2025, Eyes Future Copper-Molybdenum Projects
00:10:00
relentless mission to change the world of finance|Micky Malka,Ribbit,Ribbit Capital

© 2017 - Neuhu+